当前位置:首页 - 行情中心 - 博济医药(300404) - 财务分析 - 资产负债表

博济医药

(300404)

  

流通市值:23.30亿  总市值:32.11亿
流通股本:2.78亿   总股本:3.83亿

资产负债表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
流动资产:
货币资金153,365,620.33270,133,867.18132,940,785.41328,171,927.87
应收票据及应收账款177,424,177.9182,206,357.01173,458,968.72157,489,660.63
其中:应收票据16,301,250.0712,502,762.366,023,5502,818,618.4
应收账款161,122,927.83169,703,594.65167,435,418.72154,671,042.23
预付款项26,211,680.3723,379,037.7922,862,514.5321,942,098.6
其他应收款合计12,029,874.7310,069,166.699,468,672.778,298,851.86
存货220,311,229.03189,485,440.64228,267,247.47217,452,514.32
合同资产81,689,181.2179,624,134.8194,875,576.4665,399,760.9
其他流动资产1,346,961.141,702,764.71,828,190.182,916,918.37
流动资产平衡项目0000
流动资产合计823,520,451.16780,278,696.05812,494,881.98849,704,092.06
非流动资产:
长期股权投资7,005,935.487,064,555.156,978,057.446,209,744.68
其他权益工具投资50,698,50050,698,50051,605,16651,605,166
其他非流动金融资产96,710,347.5996,710,347.5991,710,347.5957,610,347.59
投资性房地产140,875,824.83140,397,648.55125,121,246.790,046,867.94
固定资产225,949,933.7231,454,805.21247,946,248.13285,777,264.82
在建工程--517,163.181,109,916.01
使用权资产3,616,508.263,591,190.864,121,639.676,424,829.47
无形资产21,462,738.221,316,937.9421,523,970.4821,444,700.86
商誉28,098,558.0328,098,558.0328,098,558.0328,098,558.03
长期待摊费用19,431,764.2620,010,194.6318,323,963.1617,780,752.5
递延所得税资产68,577,291.2666,465,340.0866,195,153.8162,690,490.92
其他非流动资产5,487,606.894,505,451.418,621,260.279,541,954.67
非流动资产平衡项目0000
非流动资产合计667,915,008.5670,313,529.45670,762,774.46638,340,593.49
资产平衡项目0000
资产总计1,491,435,459.661,450,592,225.51,483,257,656.441,488,044,685.55
流动负债:
短期借款1,595,0001,595,00027,035,00029,977,680.33
应付票据及应付账款120,733,905.95127,757,393.42149,639,915.29117,649,403.99
应付账款120,733,905.95127,757,393.42149,639,915.29117,649,403.99
合同负债225,776,227.47192,956,531.28182,191,223.71190,006,361.72
应付职工薪酬22,549,190.2222,306,392.7621,854,748.5821,695,925.67
应交税费8,397,265.5610,119,649.7312,872,976.839,081,096.67
其他应付款合计33,760,234.6631,128,933.9814,207,723.1814,521,098.68
应付股利13,00013,00014,00014,000
一年内到期的非流动负债3,213,264.673,719,038.213,378,310.825,409,038.34
其他流动负债9,495,253.187,930,904.826,656,713.027,652,294.67
流动负债平衡项目0000
流动负债合计425,520,341.71397,513,844.2417,836,611.43395,992,900.07
非流动负债:
长期借款39,264,235.8539,264,235.8539,264,235.8579,688,406.72
租赁负债1,954,448.821,551,617.182,410,852.93,777,339.31
预计负债377,000377,000377,000377,000
递延收益4,913,333.15,340,557.195,816,732.366,200,032.26
递延所得税负债5,058,204.194,791,627.046,146,250.456,536,382.9
非流动负债平衡项目0000
非流动负债合计51,567,221.9651,325,037.2654,015,071.5696,579,161.19
负债平衡项目0000
负债合计477,087,563.67448,838,881.46471,851,682.99492,572,061.26
所有者权益(或股东权益):
实收资本(或股本)383,170,928382,436,428382,207,238382,207,238
资本公积375,319,526.53367,977,929.57364,765,254.29365,091,382.85
减:库存股18,914,113.8118,914,113.8119,459,113.8119,459,113.81
其他综合收益3,411,750.153,494,116.632,615,193.293,113,615.43
盈余公积32,020,892.632,020,892.627,166,412.7127,166,412.71
未分配利润210,266,800.95206,366,221.23225,994,694.73212,852,089.47
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计985,275,784.42973,381,474.22983,289,679.21970,971,624.65
少数股东权益29,072,111.5728,371,869.8228,116,294.2424,500,999.64
股东权益平衡项目0000
股东权益合计1,014,347,895.991,001,753,344.041,011,405,973.45995,472,624.29
负债和股东权益合计1,491,435,459.661,450,592,225.51,483,257,656.441,488,044,685.55
公告日期2025-04-262025-04-262024-10-262024-08-27
审计意见(境内)标准无保留意见
TOP↑